Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

被引：0
|
作者：
B. L. Langdahl
F. Marin
E. Shane
H. Dobnig
J. R. Zanchetta
M. Maricic
K. Krohn
K. See
M. R. Warner
机构：
[1] Åarhus University Hospital,Lilly Research Laboratories
[2] Åarhus Sygehus,Instituto de Investigaciones Metabólicas, School of Medicine
[3] Eli Lilly and Company,undefined
[4] Columbia University,undefined
[5] Medical University of Graz,undefined
[6] USAL University,undefined
[7] Catalina Pointe Arthritis and Rheumatology Specialists,undefined
来源：
Osteoporosis International | 2009年 / 20卷
关键词：
Alendronate; Bone biomarkers; Glucocorticoid-induced osteoporosis; PINP; Premenopausal; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2095 / 2104
页数：9
相关论文
共 50 条
  • [21] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
    Minisola, Salvatore
    Scillitani, Alfredo
    Romagnoli, Elisabetta
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2156 - 2157
  • [22] Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
    Lau, Arthur N.
    Adachi, Jonathan D.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 497 - 503
  • [23] Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis Thirty-Six-Month Results of a Randomized, Double-Blind, Controlled Trial
    Saag, Kenneth G.
    Zanchetta, Jose R.
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Eastell, Richard
    See, Kyoungah
    Krege, John H.
    Krohn, Kelly
    Warner, Margaret R.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3346 - 3355
  • [24] Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
    Saag, KG
    Emkey, R
    Schnitzer, TJ
    Brown, JP
    Hawkins, F
    Goemaere, S
    Thamsborg, G
    Liberman, UA
    Delmas, PD
    Malice, MP
    Czachur, M
    Daifotis, AG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05): : 292 - 299
  • [25] The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials
    Liu, Zhi-Ming
    Zhang, Min
    Zong, Yuan
    Zhang, Ding
    Shen, Zhu-Bin
    Guan, Xiao-Qing
    Yin, Fei
    [J]. PLOS ONE, 2022, 17 (05):
  • [26] An effect comparison of alendronate and teriparatide in patients with glucocorticoid-induced osteoporosis: A protocol for systematic review and meta-analysis
    Liang, Na
    Zhang, Shuang
    Wang, Shuang
    Ma, Juan
    [J]. MEDICINE, 2022, 101 (48) : E32090
  • [27] Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis - Reply
    de Nijs, Ron N. J.
    Jacobs, Johannes W. G.
    Bijlsma, Johannes W. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20): : 2157 - 2157
  • [28] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Recknor, Chris
    See, Kyoungah
    Warner, Margaret R.
    Wong, Mayme
    Krohn, Kelly
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148
  • [29] Active Comparator Trial of Teriparatide vs Alendronate for Treating Glucocorticoid-Induced Osteoporosis: Results From the Hispanic and Non-Hispanic Cohorts
    Losada, Benito R.
    Zanchetta, Jose R.
    Zerbini, Cristiano
    Molina, Jose F.
    De la Pena, Pilar
    Liu, Charlie C.
    Smith, Rachel B.
    Nino, Antonio J.
    Krohn, Kelly
    Warner, Margaret R.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2009, 12 (01) : 63 - 70
  • [30] EXPERIENCE ON THE USE OF TERIPARATIDE FOR TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
    Saparbayeva, M.
    Issayeva, B.
    Issayeva, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S377 - S378
12345